Trials / Active Not Recruiting
Active Not RecruitingNCT07067632
To Study the Mortality Outcome of Controlled Blood Pressure Participants
Mortality Outcome of Controlled Hypertension in Randomized Controlled or Open-label Study Intentionally Directed Intervention Effect Blood Pressure: A Systematic Review and Meta-Analysis
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- DejthidaNathaphong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite advances in antihypertensive therapy, some patients with well-controlled blood pressure still experience fatal outcomes. This paradox raises critical questions about the efficacy of blood pressure-targeted interventions and whether BP control alone ensures survival. This systematic review and meta-analysis aims to evaluate all-cause mortality and cardiovascular death among hypertensive patients who achieved BP targets in RCTs or open-label trials. To determine whether achieving controlled blood pressure through intentional intervention (pharmacological or procedural) in RCTs or open-label studies reduces mortality (all-cause and cardiovascular) in hypertensive patients.
Detailed description
Sensitivity Analyses Excluding high-risk of bias studies Excluding short follow-up (\<1 year)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antihypertensive treatment | Any intervention (pharmacological, device-based, lifestyle) intentionally directed at lowering BP Control groups receiving placebo, standard of care, or no intervention |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-12-31
- Completion
- 2027-02-01
- First posted
- 2025-07-16
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT07067632. Inclusion in this directory is not an endorsement.